By accurately describing cancer genomes, we may link genomic mutations to phenotypic effects and eventually treat cancer patients based on the molecular cause of their disease, rather than generalizing treatment based on cell morphology or tissue of origin. Alteration of DNA copy number is a driving mutational process in the formation and progression of cancer. Deletions and amplifications of specific chromosomal regions are important for cancer diagnosis and prognosis, and copy number analysis has become standard practice for many clinicians and researchers. In this thesis we describe the development of two computational methods, TAPS and Patchwork, for analysis of genome-wide absolute allele-specific copy number per cell in tumour samples...
Tumorigenesis is a multi-step process in which normal cells transform into malignant tumors followin...
Ovarian cancer is a heterogeneous disease displaying complex genomic alterations, and consequently, ...
In this article, we introduce a robust and efficient strategy for deriving global and allele-specifi...
By accurately describing cancer genomes, we may link genomic mutations to phenotypic effects and eve...
Study of DNA copy-number variation is a key part of cancer genomics. With the help of a comprehensiv...
We describe a bioinformatic tool, Tumor Aberration Prediction Suite (TAPS), for the identification o...
Summary:Copy number variation is an important and abundant source of variation in the human genome, ...
Aneuploidy, loosely defined as an imbalance of chromosomes, is found in ~90% of all solid tumors and...
Cancer is a genetic disease. The activation, alteration or deactivation of cancer genes can stimulat...
International audienceIn this chapter we consider basic hypothesis, problem statements and technolog...
Genomic copy number alterations (CNA) and loss of heterozygozity (LOH) are two types of genomic inst...
Gains and losses of DNA are prevalent in cancer and emerge as a consequence of inter-related process...
Cancer is a genetic disease. Step-wise alteration of genes that have a normal function in the cell c...
35 pagesInternational audienceIn this chapter, we focus on statistical questions raised by the ident...
The application of genome-wide approaches to the molecular characterization of cancer was investigat...
Tumorigenesis is a multi-step process in which normal cells transform into malignant tumors followin...
Ovarian cancer is a heterogeneous disease displaying complex genomic alterations, and consequently, ...
In this article, we introduce a robust and efficient strategy for deriving global and allele-specifi...
By accurately describing cancer genomes, we may link genomic mutations to phenotypic effects and eve...
Study of DNA copy-number variation is a key part of cancer genomics. With the help of a comprehensiv...
We describe a bioinformatic tool, Tumor Aberration Prediction Suite (TAPS), for the identification o...
Summary:Copy number variation is an important and abundant source of variation in the human genome, ...
Aneuploidy, loosely defined as an imbalance of chromosomes, is found in ~90% of all solid tumors and...
Cancer is a genetic disease. The activation, alteration or deactivation of cancer genes can stimulat...
International audienceIn this chapter we consider basic hypothesis, problem statements and technolog...
Genomic copy number alterations (CNA) and loss of heterozygozity (LOH) are two types of genomic inst...
Gains and losses of DNA are prevalent in cancer and emerge as a consequence of inter-related process...
Cancer is a genetic disease. Step-wise alteration of genes that have a normal function in the cell c...
35 pagesInternational audienceIn this chapter, we focus on statistical questions raised by the ident...
The application of genome-wide approaches to the molecular characterization of cancer was investigat...
Tumorigenesis is a multi-step process in which normal cells transform into malignant tumors followin...
Ovarian cancer is a heterogeneous disease displaying complex genomic alterations, and consequently, ...
In this article, we introduce a robust and efficient strategy for deriving global and allele-specifi...